Atlas Trials

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

Clinical trial NCT00730665 · TERMINATED

Trial details

NCT number
NCT00730665
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2008-01-01
Primary completion
2008-10-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.